Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/27/2003US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans
03/27/2003US20030059802 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infection of gut and intestine; for use aide in digestion and nutrient absorption
03/27/2003US20030059799 Modified DNA molecule, recombinant containing the same, and uses thereof
03/27/2003US20030059796 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis
03/27/2003US20030059795 Method for accelerated genome walking and DNA fingerprinting
03/27/2003US20030059794 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds
03/27/2003US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
03/27/2003US20030059792 Apparatus for use as tool in screening genetic data in computers which is associated with signal transduction
03/27/2003US20030059791 Solid support join to preferential oligonucleotide for use as diagnostic tool in genetic analysis
03/27/2003US20030059789 Detection of preferential nucleotide sequences in sample; provide sample containing nucleotide sequences, incubate with oligonucleotides joined to solid support, detect hybridization
03/27/2003US20030059788 Evaluating toxicity of compound; obtain cells, incubate with test agent, extract nucleotide sequence, hybridize with probe, monitor hybridization profile, compare to control, similarities in pattern indicate toxicity
03/27/2003US20030059787 Detection of preferential nucleotide sequences coding telomerase; obtain sample containing nucleotide sequences, incubate with probe, detect hybridization product, presence of product indicates gene for telomerase
03/27/2003US20030059784 Compositions and methods relating to ovary specific genes and proteins
03/27/2003US20030059783 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059782 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059780 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059779 Promotor for functional characterization of G-protein coupled receptors in the yeast saccharomyces cerevisiae
03/27/2003US20030059778 Nucleic acid sequencing by Raman monitoring of uptake of precursors during molecular replication
03/27/2003US20030059776 bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003US20030059773 Immunomodulatory formulations and methods for use thereof
03/27/2003US20030059769 High affinity nucleic acid ligands to lectins
03/27/2003US20030059768 Novel polypeptides and nucleic acids encoding same
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059764 Apparatus for use in the detection and analysis of preferential cells in sample
03/27/2003US20030059763 Nucleotidesequences coding polypeptide for use as tools in human therapeutics
03/27/2003US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets
03/27/2003US20030059455 A defective recombinant adenovirus including at least one DNA sequence coding for all or an active part of a superoxide; useful for treating and/or preventing Parkinson's disease, Alzheimer's disease, Huntington's disease etc.
03/27/2003US20030059442 Attenuated microorganisms for the treatment of infection
03/27/2003US20030059441 Unmarked mutation is a mutated nucleotide sequence introduced into mycobacterium where sequence does not contain selectable marker such as gene conferring antibiotic resistance to recombinant mycobacterium incorporating mutated sequence
03/27/2003US20030059436 Band 3 antigenic peptides, malaria polypeptides and uses thereof
03/27/2003US20030059431 Prostatic growth factor
03/27/2003US20030059427 Isolation and characterization of highly active anti-CD40 antibody
03/27/2003US20030059424 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
03/27/2003US20030059421 DNA encoding the baboon and cynomolgus macaque prostoglandin E2 receptor EP4 subtype
03/27/2003US20030059420 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome
03/27/2003US20030059419 Identification of novel substrate I-TRAF of IKK-i kinase
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059414 Cell populations which co-express CD49c and CD90
03/27/2003US20030059413 For production of recombinant transduced stem/progenitor cells
03/27/2003US20030059400 Comprises DNA sequence encoding a detectable, cytotoxic protein or protein capable of inducing a detectable signal (luminescent or fluorescent); tumor imaging; gene expression
03/27/2003US20030059375 Method for treating lung cancers
03/27/2003US20030059349 Contacting of biological substances immobilized on a surface with a solution of biological surfaces
03/27/2003US20030058799 Nucleic acid sequencing by raman monitoring of molecular deconstruction
03/27/2003US20030057154 Matched Ion Polynucleotide Chromatography; eliminating multivalent cations from the all aspects of the separation process; enhances the chromatographic separation of polynucleotides on non-polar, wide pore separation media
03/27/2003US20030057108 Reduced out-of-warm-up baseline drift for chemical, electrochemical and enzyme sensors, by exposing the sensor and the calibrating solution to an elevated temperature for a given time period, and then exposing to a lower temperature
03/27/2003US20030057094 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
03/27/2003US20030056271 Front opening body armor
03/27/2003CA2709442A1 Cell populations which co-express cd49c and cd90
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2461056A1 Hiv-gag codon-optimised dna vaccines
03/27/2003CA2461050A1 Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes
03/27/2003CA2460985A1 Nestin-expressing hair follicle stem cells
03/27/2003CA2460845A1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003CA2460817A1 A method for identifying effector molecules for gene network integration
03/27/2003CA2460812A1 Lipid-associated molecules
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460805A1 Nanomachine compositions and methods of use
03/27/2003CA2460778A1 Methods for testing and producing (-) strand rna virus vectors with reduced particle formation ability
03/27/2003CA2460721A1 Genetic analysis for stratification of cancer risk
03/27/2003CA2460706A1 Trk polypeptide purification method
03/27/2003CA2460639A1 Engineered templates and their use in single primer amplification
03/27/2003CA2460632A1 Gene expression construct of hap1 adapted for plant cells
03/27/2003CA2460621A1 Novel nucleic acids and polypeptides
03/27/2003CA2460587A1 Anti-pdgf antibodies and methods for producing engineered antibodies
03/27/2003CA2460546A1 Dna polymerases and mutants thereof
03/27/2003CA2460505A1 Nucleic acid for a cloning vector
03/27/2003CA2460499A1 A gene encoding cyclododecanone monooxygenase
03/27/2003CA2460456A1 Chromogenic in situ hybridization methods, kits, and compositions
03/27/2003CA2460392A1 Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity
03/27/2003CA2460372A1 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
03/27/2003CA2460157A1 Site-specific recombinase based method for producing adenoviral vectors
03/27/2003CA2460128A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003CA2460120A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2460048A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method
03/27/2003CA2459756A1 A method to modify cell number, architecture and yield of plants by overexpressing the e2f transcription factor
03/27/2003CA2459219A1 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459137A1 Receptors and membrane-associated proteins
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2458303A1 Brain expressed cap-2 gene and protein associated with bipolar disorder
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003CA2454319A1 Multi-site mutagenesis
03/27/2003CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/27/2003CA2423849A1 Method for determining the age of individuals
03/26/2003WO2002026978A1 Novel proteins, genes encoding them and method of using the same
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1296138A1 Use of disease-associated gene
03/26/2003EP1295952A2 Methods for screening for transdominant effector peptides and RNA molecules
03/26/2003EP1295951A1 Cell library method
03/26/2003EP1295949A1 Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use
03/26/2003EP1295946A1 Sulfate transferase and dna encoding this enzyme
03/26/2003EP1295945A1 Human neuronal nictinic acetylcholine receptor compositions and mehtods employing same
03/26/2003EP1295944A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins
03/26/2003EP1295943A1 Polypeptides having activity of stimulating neutrophils
03/26/2003EP1295942A2 Method for processing a library using ligation inhibition
03/26/2003EP1295939A1 Insulin-like growth factor binding protein
03/26/2003EP1295937A2 Candida boidinii formic hydrogenase mutants
03/26/2003EP1295897A1 DNA encoding the chimpanzee prostaglandin E2 receptor EP4 subtype
03/26/2003EP1295896A1 Method for identifying or isolating a molecule and molecules identified thereby
1 ... 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 ... 4023